Lisa Levy has experience working on clinical trials that measure resistance to microbicides and pre-exposure prophylaxis (PrEP) study products, including MTN-003 (VOICE), a Phase IIB randomized clinical trial that enrolled more than 5000 participants across South Africa, Zimbabwe, and Uganda. She also led MTN-015, an observational cohort study of women following HIV-1 seroconversion in a microbicide trials study. Ms. Levy is a Senior Clinical Research and Project Manager with Science Facilitation at FHI 360.